Newark, DE-Pennystockchaser.com is pleased to profile promising special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. To view some of profiled stocks, please visit by clicking on the following link: http://www.pennystockchaser.com
Sign up for our FREE alerts at pennystockchaser.com
Genta Incorporated (OTC: GETA), last at 0.044 a share, is a biopharmaceutical company focused on the development of drugs for the treatment of cancer. Early this morning, GETA was up 1.9% and experienced a gain of +0.0008.
Emisphere Technologies, Inc. (OTC: EMIS) is in the biopharmaceutical industry, and are the developers of the Eligen Technology. EMIS’ Eligen Technology is a system that helps the body soak up select molecules. EMIS, earlier this morning, was trading at $3.44 a share, up 7.5% and experienced a gain of +0.24.
Synergy Pharmaceuticals Inc (OTC: SGYP), targeting gastrointestinal (GI) infections and diseases, is a biopharmaceutical company. SGYP, last at $10.50 a share and trading between $10.20 and $10.50, is focused on oral drugs to treat (GI). Synergy Pharmaceuticals increased 4.9% and had a gain of +0.49 in the morning.
About PennystockChaser.com
PennyStockChaser.com is an independent electronic publication that provides information on selected publicly traded companies. PennyStockChaser.com is not a registered investment advisor or broker-dealer. PennyStockChaser.com’
